Setmelanotide, an eight amino acid cyclic MC4R agonist peptide (Table 1), is being investigated in several clinical studies for the treatment of obesity, including rare genetic disorders of obesity. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.